AAAAAA

   
Results: 1-25 | 26-41
Results: 1-25/41
HIGH-DOSE THERAPY WITH STEM-CELL TRANSPLANTATION FOR MANTLE CELL LYMPHOMA - RESULTS AND PROGNOSTIC FACTORS, A SINGLE-CENTER EXPERIENCE
Authors: MILPIED N GAILLARD F MOREAU P MAHE B SOUCHET J RAPP MJ BULABOIS CE MORINEAU N HAROUSSEAU JL
Citation: N. Milpied et al., HIGH-DOSE THERAPY WITH STEM-CELL TRANSPLANTATION FOR MANTLE CELL LYMPHOMA - RESULTS AND PROGNOSTIC FACTORS, A SINGLE-CENTER EXPERIENCE, Bone marrow transplantation, 22(7), 1998, pp. 645-650
PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION AS FRONT-LINE THERAPY IN PATIENTS AGED 61 TO 65 YEARS - A PILOT-STUDY
Authors: MOREAU P MILPIED N VOILLAT L COLOMBAT P MAHE B RAPP MJ MOREAU A DUPAS B BULABOIS CE JUGEMORINEAU N HAROUSSEAU JL
Citation: P. Moreau et al., PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION AS FRONT-LINE THERAPY IN PATIENTS AGED 61 TO 65 YEARS - A PILOT-STUDY, Bone marrow transplantation, 21(12), 1998, pp. 1193-1196
PURGED OR UNPURGED AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR 66PATIENTS (PTS) WITH FOLLICULAR LYMPHOMAS (FL) - A SINGLE-CENTER EXPERIENCE
Authors: BULABOIS CE MILPIED N MAHE B MORINEAU N MOREAU P MELLERIN MP DECERVENS C MOREAU A HAROUSSEAU JL
Citation: Ce. Bulabois et al., PURGED OR UNPURGED AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR 66PATIENTS (PTS) WITH FOLLICULAR LYMPHOMAS (FL) - A SINGLE-CENTER EXPERIENCE, Bone marrow transplantation, 21, 1998, pp. 582-582
HIGH-DOSE THERAPY (HDT) WITH STEM-CELL TRANSPLANTATION (BMT) FOR MANTLE CELL LYMPHOMA (MCL) - RESULTS AND PROGNOSTIC FACTORS - A SINGLE-CENTER EXPERIENCE
Authors: MILPIED N GAILLARD F MOREAU P MAHE B SOUCHET J RAPP MJ BULABOIS CE MORINEAU N HAROUSSEAU JL
Citation: N. Milpied et al., HIGH-DOSE THERAPY (HDT) WITH STEM-CELL TRANSPLANTATION (BMT) FOR MANTLE CELL LYMPHOMA (MCL) - RESULTS AND PROGNOSTIC FACTORS - A SINGLE-CENTER EXPERIENCE, Bone marrow transplantation, 21, 1998, pp. 596-596
PILOT-STUDY OF 220 MG M2 MELPHALAN (HDM 220) FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IN 22 PATIENTS WITH ADVANCED MULTIPLE-MYELOMA (MM)
Authors: MOREAU P MILPIED N KERGUERIS MF BULABOIS CE MORINEAU N RAPP MJ MAHE B BATAILLE R HAROUSSEAU JL
Citation: P. Moreau et al., PILOT-STUDY OF 220 MG M2 MELPHALAN (HDM 220) FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IN 22 PATIENTS WITH ADVANCED MULTIPLE-MYELOMA (MM), Bone marrow transplantation, 21, 1998, pp. 715-715
QUININE IMPROVES THE RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES EXPRESSING P-GLYCOPROTEIN - RESULTS OF A RANDOMIZED STUDY
Authors: WATTEL E SOLARY E HECQUET B CAILLOT D IFRAH N BRION A MAHE B MILPIED N JANVIER M GUERCI A ROCHANT H CORDONNIER C DREYFUS F BUZYN A HOANGNGOC L STOPPA AM GRATECOS N SADOUN A STAMATOULAS A TILLY H BRICE P MALOISEL F LIOURE B DESABLENS B PIGNON B ABGRALL JP LEPORRIER M DUPRIEZ B GUYOTAT D LEPELLEY P FENAUX P
Citation: E. Wattel et al., QUININE IMPROVES THE RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES EXPRESSING P-GLYCOPROTEIN - RESULTS OF A RANDOMIZED STUDY, British Journal of Haematology, 102(4), 1998, pp. 1015-1024
IMMUNE RECONSTITUTION FOLLOWING AUTOLOGOUS CD34- LONG-LASTING CD4 T-CELLS DEFICIENCY IS NOT ASSOCIATED WITH UNUSUALLY SEVERE INFECTIONS - ASINGLE-CENTER EXPERIENCE IN 45 PATIENTS (PTS)( CELL TRANSPLANTATION )
Authors: MAHE B BULABOIS CE MORINEAU NJ MOREAU P RAPP MJ HAROUSSEAU JL MILPIED N
Citation: B. Mahe et al., IMMUNE RECONSTITUTION FOLLOWING AUTOLOGOUS CD34- LONG-LASTING CD4 T-CELLS DEFICIENCY IS NOT ASSOCIATED WITH UNUSUALLY SEVERE INFECTIONS - ASINGLE-CENTER EXPERIENCE IN 45 PATIENTS (PTS)( CELL TRANSPLANTATION ), British Journal of Haematology, 102(1), 1998, pp. 68-68
AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)
Authors: WATTEL E LELEU X SOLARY E CAILLOT D DREYFUS F BRION A MAHE B JOUET JP HOANGNGOC L MALOISEL F GUERCI A ROCHANT H GRATECOS N SADOUN A STAMATOULLAS A CASASSUS P JANVIER M STOPPA AM DESABLENS B FEGUEUX N GUYOTAT D BRICE P LEPELLEY P FENAUX P
Citation: E. Wattel et al., AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS), British Journal of Haematology, 102(1), 1998, pp. 320-321
ANALYSIS OF PLATELET RECOVERY AFTER AUTOLOGOUS TRANSPLANTATION WITH G-CSF MOBILIZED CD34+ CELLS PURIFIED FROM LEUKAPHERESIS PRODUCTS
Authors: HERMOUET S NIAUSSAT AE BRIEC A PINEAU D ROBILLARD N BATAILLE R MILPIED N HAROUSSEAU JL MAHE B
Citation: S. Hermouet et al., ANALYSIS OF PLATELET RECOVERY AFTER AUTOLOGOUS TRANSPLANTATION WITH G-CSF MOBILIZED CD34+ CELLS PURIFIED FROM LEUKAPHERESIS PRODUCTS, HEM CELL TH, 39(6), 1997, pp. 317-325
MYELOABLATIVE THERAPY WITH STEM-CELL SUPPORT (BMT) IS FEASIBLE AND EFFECTIVE IN MANTLE CELL LYMPHOMA (MCL) - A SINGLE-CENTER EXPERIENCE OVER 5 YEARS
Authors: MILPIED N GAILLARD F MOREAU P SOUCHET J MAHE B RAPP MJ BULABOIS CE MORINEAU N HAROUSSEAU JL
Citation: N. Milpied et al., MYELOABLATIVE THERAPY WITH STEM-CELL SUPPORT (BMT) IS FEASIBLE AND EFFECTIVE IN MANTLE CELL LYMPHOMA (MCL) - A SINGLE-CENTER EXPERIENCE OVER 5 YEARS, Experimental hematology, 25(8), 1997, pp. 18-18
INTENSIVE CHEMOTHERAPY WITH QUININE IN MYELODYSPLASTIC SYNDROMES (MDS)
Authors: WATTEL E SOLARY E CAILLOT D DREYFUS F BRION A MAHE B HOANGNGOC L MALOISEL F GUERCI A ROCHANT H GRATECOS N SADOUN A STAMATOULLAS A CASASSUS P JANVIER M STOPPA AM DESABLENS B FEGEUX N IFRAH N ABGRALL JP GUYOTAT D DUPRIEZ B PENY AM BRICE P PIGNON B LEPORRIER M LEPELLEY P FENAUX P
Citation: E. Wattel et al., INTENSIVE CHEMOTHERAPY WITH QUININE IN MYELODYSPLASTIC SYNDROMES (MDS), Experimental hematology, 25(8), 1997, pp. 34-34
HIGH-DOSE THERAPY WITH STEM-CELL SUPPORT IN 7 PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL), PRETREATED WITH 2 OR 3 LINES OF THERAPY INCLUDING FLUDARABINE
Authors: MAHE B MILPIED N BULABOIS CE JUGEMORINEAU N MOREAU P HAROUSSEAU IL
Citation: B. Mahe et al., HIGH-DOSE THERAPY WITH STEM-CELL SUPPORT IN 7 PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL), PRETREATED WITH 2 OR 3 LINES OF THERAPY INCLUDING FLUDARABINE, Experimental hematology, 25(8), 1997, pp. 318-318
AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)
Authors: WATTEL E SOLARY E CAILLOT D DREYFUS F BRION A MAHE B JOUET JP HOANGNGOC L MALOISEL F GUERCI A ROCHANT H GRATECOS N SADOUN A STAMATOULLAS A CASASSUS P JANVIER M STOPPA AM DESABLENS B FEGEUX N GUYOTAT D BRICE P LEPELLEY P FENAUX P
Citation: E. Wattel et al., AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS), Experimental hematology, 25(8), 1997, pp. 320-320
TREATMENT OF GRAFT-VERSUS-HOST DISEASE BY EXTRACORPOREAL PHOTOCHEMOTHERAPY
Authors: BESNIER DP CHABANNES D MAHE B MUSSINI JMG BARANGER TAR MULLER JY MILPIED N ESNAULT VLM
Citation: Dp. Besnier et al., TREATMENT OF GRAFT-VERSUS-HOST DISEASE BY EXTRACORPOREAL PHOTOCHEMOTHERAPY, Transplantation, 64(1), 1997, pp. 49-54
PURGED OR UNPURGED AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR 66PATIENTS (PTS) WITH FOLLICULAR LYMPHOMAS (FL) - A SINGLE-CENTER EXPERIENCE
Authors: BULABOIS CE MILPIED N MAHE B MORINEAU N MOREAU P MELLERIN MP DECERVENS C MOREAU A HAROUSSEAU JL
Citation: Ce. Bulabois et al., PURGED OR UNPURGED AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR 66PATIENTS (PTS) WITH FOLLICULAR LYMPHOMAS (FL) - A SINGLE-CENTER EXPERIENCE, Blood, 90(10), 1997, pp. 4548-4548
HIGH-DOSE THERAPY (HDT) WITH STEM-CELL TRANSPLANTATION (BMT) FOR MANTLE CELL LYMPHOMA (MCL) - RESULTS AND PROGNOSTIC FACTORS - A SINGLE-CENTER EXPERIENCE
Authors: MILPIED N GAILLARD F MOREAU P MAHE B SOUCHET J RAPP MJ BULABOIS CE MORINEAU N HAROUSSEAU JL
Citation: N. Milpied et al., HIGH-DOSE THERAPY (HDT) WITH STEM-CELL TRANSPLANTATION (BMT) FOR MANTLE CELL LYMPHOMA (MCL) - RESULTS AND PROGNOSTIC FACTORS - A SINGLE-CENTER EXPERIENCE, Blood, 90(10), 1997, pp. 1693-1693
PILOT-STUDY OF 220 MG M(2) MELPHALAN (HDM-220) FOLLOWED BY AUTOLOGOUSSTEM-CELL TRANSPLANTATION (ASCT) IN 22 PATIENTS WITH ADVANCED MULTIPLE-MYELOMA (MM)/
Authors: MOREAU P MILPIED N KERGUERIS MF BULABOIS CE MORINEAU N RAPP MJ MAHE B BATAILLE R HAROUSSEAU JL
Citation: P. Moreau et al., PILOT-STUDY OF 220 MG M(2) MELPHALAN (HDM-220) FOLLOWED BY AUTOLOGOUSSTEM-CELL TRANSPLANTATION (ASCT) IN 22 PATIENTS WITH ADVANCED MULTIPLE-MYELOMA (MM)/, Blood, 90(10), 1997, pp. 1708-1708
SUCCESSFUL ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR EARLY RELAPSE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN 2 CASES OF AGGRESSIVE HIGH-GRADE NON-HODGKINS-LYMPHOMA
Authors: MOREAU P MECHINAUD F MAHE B LETORTOREC S RAPP MJ MAISONNEUVE H HAROUSSEAU JL MILPIED N
Citation: P. Moreau et al., SUCCESSFUL ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR EARLY RELAPSE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN 2 CASES OF AGGRESSIVE HIGH-GRADE NON-HODGKINS-LYMPHOMA, Bone marrow transplantation, 18(3), 1996, pp. 665-667
A PILOT-STUDY OF 220 MG M(2) MELPHALAN FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES - PHARMACOKINETICS AND TOXICITY/
Authors: MOREAU P KERGUERIS MF MILPIED N LETORTOREC S MAHE B BULABOIS CE RAPP MJ LAROUSSE C BATAILLE R HAROUSSEAU JL
Citation: P. Moreau et al., A PILOT-STUDY OF 220 MG M(2) MELPHALAN FOLLOWED BY AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES - PHARMACOKINETICS AND TOXICITY/, British Journal of Haematology, 95(3), 1996, pp. 527-530
G-CSF ALONE MOBILIZES SUFFICIENT PERIPHERAL-BLOOD CD34(-DIAGNOSED PATIENTS WITH MYELOMA AND LYMPHOMA() CELLS FOR POSITIVE SELECTION IN NEWLY)
Authors: MAHE B MILPIED N HERMOUET S ROBILLARD N MOREAU P LETORTOREC S RAPP MJ BATAILLE R HAROUSSEAU JL
Citation: B. Mahe et al., G-CSF ALONE MOBILIZES SUFFICIENT PERIPHERAL-BLOOD CD34(-DIAGNOSED PATIENTS WITH MYELOMA AND LYMPHOMA() CELLS FOR POSITIVE SELECTION IN NEWLY), British Journal of Haematology, 92(2), 1996, pp. 263-268
A RANDOMIZED TRIAL OF HYDROXYUREA VERSUS VP16 IN ADULT CHRONIC MYELOMONOCYTIC LEUKEMIA
Authors: WATTEL E GUERCI A HECQUET B ECONOMOPOULOS T COPPLESTONE A MAHE B COUTEAUX ME RESEGOTTI L VOGLOVA V FOUSSARD C PEGOURIE B MICHAUX JJ DECONINCK E STOPPA AM MUFTI G OSCIER D FENAUX P
Citation: E. Wattel et al., A RANDOMIZED TRIAL OF HYDROXYUREA VERSUS VP16 IN ADULT CHRONIC MYELOMONOCYTIC LEUKEMIA, Blood, 88(7), 1996, pp. 2480-2487
PROSPECTIVE-STUDY OF AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)
Authors: WATTEL E SOLARY E CAILLOT D DREYFUS F BRION A MAHE B JOUET IP HOANGNGOC L MALOISEL F GUERCI A ROCHANT H GRATECOS N SADOUN A STAMATOULLAS A CASASSUS P JANVIER M STOPPA AM DESABLENS B FEGEUX N GUYOTAT D BRICE P LEPELLEY P FENAUX P
Citation: E. Wattel et al., PROSPECTIVE-STUDY OF AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS), Blood, 88(10), 1996, pp. 507-507
TRANSPLANTATION WITH CD34(-BLOOD PROGENITOR-CELL (PBPC) MOBILIZED WITH G-CSF ALONE IN HIGH-RISK MULTIPLE-MYELOMA (MM) - ONE-CENTER STUDY IN17 PATIENTS (PTS)() AUTOLOGOUS PERIPHERAL)
Authors: MAHE B MOREAU P LETORTOREC S BULABOIS C RAPP MI CASSIDANIUS A BERCEGEAY S DEHAUT F MILPIED N HAROUSSEAU JL
Citation: B. Mahe et al., TRANSPLANTATION WITH CD34(-BLOOD PROGENITOR-CELL (PBPC) MOBILIZED WITH G-CSF ALONE IN HIGH-RISK MULTIPLE-MYELOMA (MM) - ONE-CENTER STUDY IN17 PATIENTS (PTS)() AUTOLOGOUS PERIPHERAL), Blood, 88(10), 1996, pp. 1611-1611
QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP)
Authors: WATTEL E SOLARY E CAILLOT D DREYFUS F BRION A MAHE B HOANGNGOC L MALOSIEL F GUERCI A ROCHANT H GRATECOS N SADOUN A STAMATOULLAS A CASASSUS P JANVIER M STOPPA AM DESABLENS B FEGEUX N IFRAH N ABGRALL IP GUYOTAT D DUPRIEZ B PENY AM BRICE P PIGNON B LEPORRIER M LEPELLEY P FENAUX P
Citation: E. Wattel et al., QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP), Blood, 88(10), 1996, pp. 1807-1807
OCCURRENCE OF A T-CELL LYMPHOMA IN A PATIENT WITH CHRONIC MYELOID-LEUKEMIA TREATED WITH ALPHA-INTERFERON
Authors: MAHE B GAILLARD F LABADIE F PAPIN S LETORTOREC S MOREAU P HAROUSSEAU JL MILPIED N
Citation: B. Mahe et al., OCCURRENCE OF A T-CELL LYMPHOMA IN A PATIENT WITH CHRONIC MYELOID-LEUKEMIA TREATED WITH ALPHA-INTERFERON, Leukemia & lymphoma, 19(5-6), 1995, pp. 515-517
Risultati: 1-25 | 26-41